|
|||||
|
|
A direct comparison of long‐ and short‐acting GLP‐1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment |
|
| Authors: | A. Gastaldelli B. Balas R. Ratner J. Rosenstock B. Charbonnel G. B. Bolli M. Boldrin R. Balena |
| Affiliation: | 1. Institute of Clinical Physiology, CNR, , Pisa, Italy;2. F. Hoffmann‐La Roche, , Basel, Switzerland;3. Medstar Research Institute, , Hyattsville, MD, USA;4. Dallas Diabetes and Endocrine Center at Medical City, , Dallas, TX, USA;5. Clinique d'Endocrinologie, Université de Nantes, , Nantes, France;6. Department of Medicine, University of Perugia, , Perugia, Italy;7. Roche Pharmaceuticals, , Nutley, NJ, USA |
| Abstract: | |
| Keywords: | incretin therapy insulin resistance insulin secretion type 2 diabetes |